Details for New Drug Application (NDA): 075093
✉ Email this page to a colleague
NDA 075093 describes PENTOXIFYLLINE, which is a drug marketed by Ani Pharms, Apotex, Bausch, Heritage, Impax Labs, Pliva, and Rising, and is included in nine NDAs. It is available from seven suppliers. Additional details are available on the PENTOXIFYLLINE profile page.
The generic ingredient in PENTOXIFYLLINE is pentoxifylline. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.
The generic ingredient in PENTOXIFYLLINE is pentoxifylline. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.
Summary for 075093
| Tradename: | PENTOXIFYLLINE |
| Applicant: | Impax Labs |
| Ingredient: | pentoxifylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 075093
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 400MG | ||||
| Approval Date: | Aug 10, 1999 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
